Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters

Database
Language
Affiliation country
Publication year range
1.
Nutrients ; 15(23)2023 Nov 25.
Article in English | MEDLINE | ID: mdl-38068782

ABSTRACT

The purpose of this study was to determine the effects of pre-exercise amino acid (AA) supplementation on post-exercise iron regulation. Ten healthy males participated under two different sets of conditions in a randomized, double-blind, crossover design with a washout period of at least 21 days. Participants received either an AA supplement or placebo (PLA) for five consecutive days (4 g/dose, 3 doses/day). On the sixth day, participants ran on a treadmill for 60 min at 70% of maximal oxygen consumption (V˙O2max). Venous blood samples were collected before (baseline), immediately after, and 1 and 3 h after exercise. The serum hepcidin levels increased significantly 3 h post-exercise in both trials when compared to the baseline (p < 0.001), but the levels were not different between trials. The plasma interleukin-6 (IL-6) level significantly increased immediately after exercise compared to the baseline (p < 0.001) and was significantly higher in the AA trial than in the PLA trial (p = 0.014). Moreover, the exercise-induced increase in serum glycerol level was significantly higher in the AA trial (21.20 ± 3.98 mg/L) than in the PLA trial (17.28 ± 4.47 mg/L, p = 0.017). No significant differences were observed between the AA and PLA trials for serum iron, ferritin, and total ketone body levels (p > 0.05). In conclusion, five days of AA supplementation augmented exercise-induced increases in IL-6 and glycerol in healthy males. However, it did not affect post-exercise iron status or regulation.


Subject(s)
Interleukin-6 , Iron , Male , Humans , Glycerol , Hepcidins , Dietary Supplements , Amino Acids , Polyesters
2.
Food Chem Toxicol ; 158: 112618, 2021 Dec.
Article in English | MEDLINE | ID: mdl-34662692

ABSTRACT

Optimising nutrition intake is a key component for supporting athletic performance and supporting adaption to training. Athletes often use micronutrient supplements in order to correct vitamin and mineral deficiencies, improve immune function, enhance recovery and or to optimise their performance. The aim of this review was to investigate the recent literature regarding micronutrients (specifically iron, vitamin C, vitamin E, vitamin D, calcium) and their effects on physical performance. Over the past ten years, several studies have investigated the impacts of these micronutrients on aspects of athletic performance, and several reviews have aimed to provide an overview of current use and effectiveness. Currently the balance of the literature suggests that micronutrient supplementation in well-nourished athletes does not enhance physical performance. Excessive intake of dietary supplements may impair the body's physiological responses to exercise that supports adaptation to training stress. In some cases, micronutrient supplementation is warranted, for example, with a diagnosed deficiency, when energy intake is compromised, or when training and competing at altitude, however these micronutrients should be prescribed by a medical professional. Athletes are encouraged to obtain adequate micronutrients from a wellbalanced and varied dietary intake.


Subject(s)
Antioxidants/pharmacology , Athletic Performance , Minerals/pharmacology , Nutritional Status , Sports Nutritional Physiological Phenomena , Sports , Vitamins/pharmacology , Antioxidants/administration & dosage , Ascorbic Acid/administration & dosage , Ascorbic Acid/pharmacology , Calcium/administration & dosage , Calcium/pharmacology , Deficiency Diseases/drug therapy , Diet , Dietary Supplements , Female , Humans , Iron/administration & dosage , Iron/pharmacology , Male , Micronutrients/administration & dosage , Micronutrients/pharmacology , Minerals/administration & dosage , Trace Elements , Vitamin D/administration & dosage , Vitamin D/pharmacology , Vitamin E/administration & dosage , Vitamin E/pharmacology , Vitamins/administration & dosage
3.
J Sports Sci ; 39(14): 1565-1575, 2021 Jul.
Article in English | MEDLINE | ID: mdl-33583330

ABSTRACT

Iron deficiency is a common nutrient deficiency within athletes, with sport scientists and medical professionals recognizing that athletes require regular monitoring of their iron status during intense training periods. Revised considerations for athlete iron screening and monitoring have suggested that males get screened biannually during heavy training periods and females require screening biannually or quarterly, depending on their previous history of iron deficiency. The prevalence of iron deficiency in female athletes is higher than their male counterparts and is often cited as being a result of the presence of a menstrual cycle in the premenopausal years. This review has sought to revise our current understanding of female physiology and the interaction between primary reproductive hormones (oestrogen and progesterone) and iron homoeostasis in females. The review highlights an apparent symbiotic relationship between iron metabolism and the menstrual cycle that requires additional research as well as identifying areas of the menstrual cycle that may be primed for nutritional iron supplementation.


Subject(s)
Athletes , Iron/metabolism , Menstrual Cycle/physiology , Estrogens/metabolism , Female , Hepcidins/metabolism , Humans , Progesterone/metabolism
4.
Eur J Appl Physiol ; 120(6): 1331-1340, 2020 Jun.
Article in English | MEDLINE | ID: mdl-32303828

ABSTRACT

Hepcidin is a novel factor for iron deficiency in athletes, which is suggested to be regulated by interleukin-6 (IL-6) or erythropoietin (EPO). PURPOSE: The purpose of the present study was to compare endurance exercise-induced hepcidin elevation among "normoxia", "hypoxia" and "combined heat and hypoxia". METHODS: Twelve males (21.5 ± 0.3 years, 168.1 ± 1.2 cm, 63.6 ± 2.0 kg) participated in the present study. They performed 60 min of cycling at 60% of [Formula: see text] in either "heat and hypoxia" (HHYP; FiO2 14.5%, 32 °C), "hypoxia" (HYP; FiO2 14.5%, 23 °C) or "normoxia" (NOR; FiO2 20.9%, 23 °C). After completing the exercise, participants remained in the prescribed conditions for 3 h post-exercise. Blood samples were collected before, immediately and 3 h after exercise. RESULTS: Plasma IL-6 level significantly increased immediately after exercise (P < 0.05), with no significant difference among the trials. A significant elevation in serum EPO was observed 3 h after exercise in hypoxic trials (HHYP and HYP, P < 0.05), with no significant difference between HHYP and HYP. Serum hepcidin level increased 3 h after exercise in all trials (NOR, before 18.3 ± 3.9 and post180 31.2 ± 6.3 ng/mL; HYP, before 13.5 ± 2.5 and post180 23.3 ± 3.6 ng/mL, HHYP; before 15.8 ± 3.3 and post180 31.4 ± 5.3 ng/mL, P < 0.05). However, there was no significant difference among the trials during post-exercise. CONCLUSION: Endurance exercise in "combined heat and hypoxia" did not exacerbate exercise-induced hepcidin elevation compared with the same exercise in "hypoxia" or "normoxia".


Subject(s)
Bicycling/physiology , Exercise/physiology , Heat-Shock Response/physiology , Hepcidins/blood , Hypoxia/physiopathology , Erythropoietin/blood , Humans , Hypoxia/blood , Interleukin-6/blood , Male , Physical Endurance , Young Adult
5.
Nutrients ; 10(10)2018 Sep 21.
Article in English | MEDLINE | ID: mdl-30248915

ABSTRACT

Caffeine use is widespread among athletes following its removal from the World Anti-Doping Agency banned list, with approximately 75% of competitive athletes using caffeine. While literature supports that caffeine has a small positive ergogenic effect for most forms of sports and exercise, there exists a significant amount of inter-individual difference in the response to caffeine ingestion and the subsequent effect on exercise performance. In this narrative review, we discuss some of the potential mechanisms and focus on the role that genetics has in these differences. CYP1A2 and ADORA2A are two of the genes which are thought to have the largest impact on the ergogenicity of caffeine. CYP1A2 is responsible for the majority of the metabolism of caffeine, and ADORA2A has been linked to caffeine-induced anxiety. The effects of CYP1A2 and ADORA2A genes on responses to caffeine will be discussed in detail and an overview of the current literature will be presented. The role of these two genes may explain a large portion of the inter-individual variance reported by studies following caffeine ingestion. Elucidating the extent to which these genes moderate responses to caffeine during exercise will ensure caffeine supplementation programs can be tailored to individual athletes in order to maximize the potential ergogenic effect.


Subject(s)
Caffeine/pharmacology , Central Nervous System Stimulants/pharmacology , Cytochrome P-450 CYP1A2/genetics , Exercise/physiology , Performance-Enhancing Substances/pharmacology , Physical Endurance/genetics , Receptor, Adenosine A2A/genetics , Anxiety/genetics , Athletes/psychology , Athletic Performance/psychology , Cytochrome P-450 CYP1A2/metabolism , Dietary Supplements , Doping in Sports , Exercise/psychology , Humans , Individuality , Physical Endurance/drug effects , Precision Medicine , Receptor, Adenosine A2A/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL